1133170-61-2Relevant academic research and scientific papers
TREATMENT OF NEURODEGENERATIVE DISEASES USING INDATRALINE ANALOGS
-
, (2009/04/25)
Methods and compositions useful in the treatment or prevention of synucleinopathies, such as Parkinson''s disease, diffuse Lewy body disease, and multiple system atrophy, or other neurodegenerative diseases (e.g., amyotrophic lateral sclerosis, Huntington''s disease, and Alzheimer''s disease) are provided. The treatment including administering to a subject an indatraline derivative that inhibits the aggregation of a-synuclein.
